Zepp Health (NYSE:ZEPP) Insider Sells $17,386.59 in Stock

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) insider Pengtao Yu sold 4,251 shares of the stock in a transaction on Thursday, September 24th. The stock was sold at an average price of $4.09, for a total transaction of $17,386.59. Following the completion of the sale, the insider owned 98,491 shares in the company, valued at approximately $402,828.19. This trade represents a 4.14% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Zepp Health Price Performance

ZEPP opened at $4.12 on Friday. The stock has a market cap of $60.55 million, a P/E ratio of -1.50 and a beta of 1.87. Zepp Health Corporation Sponsored ADR has a 12 month low of $3.85 and a 12 month high of $61.85. The company has a quick ratio of 0.70, a current ratio of 0.90 and a debt-to-equity ratio of 0.30. The company has a fifty day simple moving average of $4.88 and a 200 day simple moving average of $8.51.

Hedge Funds Weigh In On Zepp Health

Several hedge funds have recently made changes to their positions in the business. Engineers Gate Manager LP lifted its stake in shares of Zepp Health by 44.4% during the 2nd quarter. Engineers Gate Manager LP now owns 20,917 shares of the company’s stock worth $109,000 after buying an additional 6,433 shares during the last quarter. AXQ Capital LP bought a new position in Zepp Health in the 2nd quarter valued at about $85,000. Monolith Management Ltd acquired a new stake in Zepp Health during the fourth quarter worth approximately $3,601,000. Finally, Harvest Fund Management Co. Ltd lifted its position in Zepp Health by 6.7% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after acquiring an additional 2,800 shares during the last quarter. 52.61% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ZEPP has been the topic of several research reports. Wall Street Zen cut shares of Zepp Health from a “hold” rating to a “sell” rating in a research report on Tuesday, September 8th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zepp Health in a report on Tuesday, September 8th. Finally, Fundamental Research set a $53.01 price target on Zepp Health and gave the company a “buy” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Zepp Health currently has a consensus rating of “Hold” and an average target price of $53.01.

About Zepp Health

Zepp Health Corporation (NYSE: ZEPP) is a wearable technology company that develops smart health and fitness devices, along with digital platforms and services designed to help consumers monitor and improve their wellness. Its products collect and analyze information such as activity, sleep, heart rate and other health-related metrics.

The company’s principal consumer brand is Amazfit, which offers smartwatches, fitness trackers and related accessories. Zepp Health also operates the Zepp brand of digital health software and services and has introduced products and services focused on areas such as sleep and hearing health.